23B Protection of confidential supporting information about innovative medicines

Where the Minister receives, or received not more than 5 years before the commencement date, an innovative medicine application and confidential supporting information, the Minister, during the protected period in relation to that confidential supporting information,—

(a)

shall take reasonable steps to ensure that that confidential supporting information is kept confidential to the Minister; and

(b)

shall not use that confidential supporting information for the purposes of determining whether to grant any other application.

Section 23B: inserted, on 1 January 1995, by section 2 of the Medicines Amendment Act 1994 (1994 No 128).